【レポートの概要（一部）】
1. Report Overview
1.1 Global Allergic Rhinitis Drugs: Market Overview
1.2 Global Allergic Rhinitis Drugs Market Segmentation
1.3 Overview of Findings
1.4 Structure of the Report
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Who is This Report For?
1.9 Methodology
1.10 Frequently Asked Questions (FAQ)
1.11 Associated Visiongain Reports
1.12 About Visiongain
2. An Introduction to Allergic Rhinitis Drugs
2.1 The Pharmaceutical Industry: A Brief Introduction
2.1.1 Allergic Rhinitis Treatments – An Industry Overview
2.2 A Brief Overview of Allergy
2.3 Allergic Rhinitis
2.3.1 The Global Prevalence of Allergic Rhinitis
2.3.2 Pathophysiology of Allergic Rhinitis: IgEs and Mast Cells
2.3.3 Symptoms of Allergic Rhinitis
2.3.4 Classification of Allergic Rhinitis
2.3.4.1 Non-Allergic Rhinitis and Mixed Rhinitis
2.3.5 Seasonal Allergic Rhinitis (Hay Fever)
2.3.6 Perennial Allergic Rhinitis
2.3.7 Diagnosis of Allergic Rhinitis
2.4 Treatment of Allergic Rhinitis
2.4.1 Antihistamines
2.4.1.1 First-Generation Antihistamines
2.4.1.2 Second- And Third-Generation Antihistamines
2.4.2 Corticosteroids
2.4.2.1 First-, Second- And Third-Generation Intranasal Corticosteroids
2.4.2.2 Combination Drug Products
2.4.3 Leukotriene Receptor Antagonists
2.4.4 Cromolyn (cromoglicic acid)
2.4.5 Decongestants
2.4.6 Saline Nasal Sprays
2.4.7 Immunotherapy and Vaccines
2.5 Phases of Clinical Trials
2.6 Scope of this Report
3. The Global Allergic Rhinitis Drugs Market, 2016-2026
3.1 The Global Allergic Rhinitis Drugs Market: Market Overview
3.2 Categorisation Of The Global Allergic Rhinitis Drugs Market
3.3 The Global Allergic Rhinitis Drugs Market in 2015
3.4 The Global Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
3.5 Allergic Rhinitis Drugs: Changing Market Shares by Sector 2016-2026
4. Oral Antihistamines Market: Market Analysis And Forecast 2016-2026
4.1 Oral Antihistamines: Market Overview
4.1.1 Leading Products in the Oral Antihistamines Market, 2015
4.2 Oral Antihistamines: Market Trends and Developments, 2016
4.2.1 Patent Expiries and the Threat of Generics
4.2.2 The Increasing Switch from Prescription to Over-The-Counter Sales
4.2.3 The Potential for Combination Therapy with Intranasal Corticosteroids
4.3 Oral Antihistamines: Market Forecast 2016-2026
4.3.1 Oral Antihistamines: Changing Market Shares by Leading Drugs 2016-2026
4.4 Leading Oral Antihistamines for the Treatment of Allergic Rhinitis
4.4.1 Allegra/Allegra-D/Allegra OTC (fexofenadine) – Sanofi
4.4.1.1 Allegra/Allegra OTC: Historical Sales, 1995-2014
4.4.1.2 Allegra/Allegra OTC: Sales Forecast 2015-2026
4.4.2 Claritin/Claritin OTC (loratadine) – Bayer/ Merck & Co
4.4.2.1 Claritin/Claritin OTC: Sales Forecast 2016-2026
4.4.3 Zyrtec/Zyrtec D (cetirizine) – Johnson & Johnson/ UCB/ GSK
4.4.3.1 Zyrtec/Zyrtec D: Sales Forecast 2016-2026
4.4.5 Xyzal (levocetirizine) – Sanofi/ UCB/ GSK
4.4.5.1 Xyzal: Sales Forecast 2016-2026
4.4.6 Clarinex (desloratadine) – Merck & Co.
4.4.6.1 Clarinex: Sales Forecast 2016-2026
4.4.7 Allelock (olopatadine) – Kyowa Hakko Kirin
4.4.7.1 Allelock: Sales Forecast 2016-2026
4.4.8 Ebastel (ebastine) – AstraZeneca/Takeda/Dainippon Sumitomo
4.4.8.1 Ebastel: Sales Forecast 2016-2026
4.4.9 Talion (bepotastine) – Mitsubishi Tanabe
4.4.9.1 Talion: Sales Forecast 2016-2026
4.4.10 Other Oral Antihistamines: Sales Forecast 2016-2026
5. Intranasal Corticosteroids Market: Market Analysis and Forecast 2016-2026
5.1 Leading Products in the Intranasal Corticosteroids Market, 2015
5.2 Intranasal Corticosteroids: Market Forecast 2016-2026
5.2.1 Intranasal Corticosteroids: Changing Market Shares By Leading Drugs 2016-2026
5.3 Leading Intranasal Corticosteroids
5.3.1 Flixonase/Flonase/Flonase-OTC (fluticasone propionate) – GlaxoSmithKline
5.3.1.1 Flixonase/Flonase/Flonase-OTC Forecast, 2016-2026
5.3.2 Nasonex (mometasone) – Merck
5.3.2.1 Nasonex Forecast, 2016-2026
5.3.3 Avamys/Veramyst (fluticasone furoate) – GlaxoSmithKline
5.3.3.1 Avamys/Veramyst Forecast, 2016-2026
5.3.4 Rhinocort (budesonide) – AstraZeneca
5.3.4.1 Rhinocort Forecast, 2016-2026
5.3.5 Nasacort/Nasacort-OTC (triamcinolone) – Sanofi
5.3.5.1 Nasacort/Nasacort-OTC Forecast, 2016-2026
5.3.6 Omnaris (ciclesonide) – Dainippon Sumitomo/Takeda
5.3.6.1 Omnaris: Sales Forecast, 2016-2026
5.3.7 Beconase/Beconase AQ (beclometasone) – GlaxoSmithKline/Omega Pharma
5.3.7.1 Beconase/Beconase AQ Forecast, 2016-2026
5.3.8 Qnasl (beclometasone) – Teva
5.3.8.1 Qnas Forecast, 2016-2026
5.3.9 Zetonna (ciclesonide) – Dainippon Sumitomo
5.3.9.1 Zetonna Forecast, 2016-2026
6. Immunotherapy and Vaccines: Market Analysis and Forecast 2016-2026
6.1 Immunotherapy and Vaccines: Market Overview
6.1.1 Immunotherapy: Primed for Rapid Expansion
6.2 Leading Immunotherapy Products in the Allergic Rhinitis Market, 2015
6.3 Allergic Rhinitis Immunotherapy: Market Trends and Developments, 2016
6.3.1 Subcutaneous and Sublingual Immunotherapy
6.3.2 Expansion into the US Market
6.3.3 Standardisation of Immunotherapy Products
6.3.4 Immunotherapy as a Preventative Treatment
6.4 Allergic Rhinitis Immunotherapy: Market Forecast 2016-2026
6.4.1 Allergic Rhinitis Immunotherapy: Changing Market Shares by Leading Products 2016-2026
6.5 Immunotherapy Type – By Route of Administration, 2015
6.6 Leading Immunotherapy Products for Allergic Rhinitis
6.6.1 Staloral (Grass pollen allergen extract) – Stallergenes
6.6.1.1 Staloral: Sales Forecast 2016-2026
6.6.2 Alutard SQ (Grass pollen allergen extract) – ALK-Abelló
6.6.2.1 Alutard SQ: Sales Forecast 2016-2026
6.6.3 Grazax/Grastek (Timothy grass pollen allergen extract) – ALK-Abelló/Merck
6.6.3.1 Grazax/Grastek: Sales Forecast 2016-2026
6.6.4 Oralair (Grass pollen allergen extract) – Stallergenes/Greer
6.6.4.1 Oralair: Sales Forecast 2016-2026
6.6.5 Ragwitek (Short ragweed pollen allergen extract) – Merck
6.6.5.1 Ragwitek: Sales Forecast 2016-2026
6.6.6 Other Allergic Rhinitis Immunotherapy Products: Sales Forecast 2016-2026
7. The Intranasal Antihistamines Market: Market Analysis and Forecast 2016-2026
7.1 Leading Products in the Intranasal Antihistamines Market, 2015
7.2 Intranasal Antihistamines: Market Trends and Developments, 2016
7.3 Intranasal Antihistamines: Market Forecast 2016-2026
7.4 Leading Intranasal Antihistamines
7.4.1 Dymista (azelastine/fluticasone) – Meda Pharmaceuticals
7.4.1.1 Mylan Acquires Meda Pharmaceuticals
7.4.1.2 Dymista: Sales Forecast 2016-2026
7.4.2 Generic Intranasal Azelastine
7.4.2.1 Generic Intranasal Azelastine: Sales Forecast, 2016-2026
7.4.3 Astepro (azelastine) – Meda Pharmaceuticals
7.4.3.1 Astepro: Sales Forecast 2016-2026
7.4.4 Patanase (olopatadine) – Novartis
7.4.4.1 Patanase: Sales Forecast 2016-2026
7.4.5 Astelin (azelastine) – Meda Pharmaceuticals
7.4.5.1 Astelin: Sales Forecast 2016-2026
8. Leading National Markets for Allergic Rhinitis Drugs, 2016-2026
8.1 The Allergic Rhinitis Drugs Market by Region
8.1.1 The Global Distribution of Allergic Rhinitis Drugs in 2015
8.2 Leading National Markets: Forecast 2016-2026
8.2.1 Changing Market Shares by Region, 2016-2026
8.3 Regional Allergic Rhinitis Drugs Markets: Analysis and Forecasts, 2016-2026
8.3.1 United States: The Largest Allergic Rhinitis Drugs Market
8.3.1.1 US Allergic Rhinitis Drugs Market: Trends and Developments
8.3.1.1.1 The Trend of Rx-to-OTC Switching
8.3.1.2 US Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.3.2 EU5
8.3.2.1 EU5 Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.3.2.2 EU5 Markets: Changing Market Shares by Country, 2016-2026
8.3.2.3 Germany
8.3.2.3.1 Germany: Reform of AMNOG Pharmaceutical Rebate Law
8.3.2.3.2 German Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.3.2.4 UK
8.3.2.4.1 UK: Increasing Burden of Allergy
8.3.2.4.2 UK Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.3.2.5 France
8.3.2.5.1 France: Social Security Finance Act 2015
8.3.2.5.2 French Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.3.2.6 Italy
8.3.2.6.1 Italy: Government Cost Cutting Measures Impacting Market Growth
8.3.2.6.2 Italian Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.3.2.7 Spain
8.3.2.7.1 Spanish Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.6 China
8.6.1 Air Pollution Associated With Increasing Prevalence
8.6.2 Expansion of Healthcare Coverage and Reimbursement in China
8.6.3 Chinese Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.7 Japan
8.7.1 Cedar Reforestation and the Hay Fever Epidemic
8.7.2 Genetically Modified Rice as Immunotherapy
8.7.3 Effects of the Rising Levels of Generic Drug Penetration
8.7.4 Japanese Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.8 Russia
8.8.1 How Will Russia’s Economic Status Affect Its Pharma Industry?
8.8.2 Russian Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.9 India
8.9.1 The Impact of the Drug Prices Control Order on Indian Pharma
8.9.2 India’s Expansion of Healthcare Provision
8.9.3 Indian Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.10 Brazil
8.10.1 How Will Brazil’s Growing Healthcare Influence Allergic Rhinitis Drugs
8.10.2 Brazilian Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.12 Rest of the World
8.12.1 Rest of the World Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
9. Leading Companies in the Allergic Rhinitis Drugs Market, 2016-2026
9.1 Allergic Rhinitis Drugs – An Evolving Market Space
9.1.1 Leading Companies in the Allergic Rhinitis Drugs Market, 2016
9.2 ALK-Abelló
9.2.1 ALK-Abelló: Allergic Rhinitis Drugs Portfolio, 2016
9.2.2 ALK-Abelló: Recent Developments
9.2.2.1 Acarizax Launched in Europe progressing to International Roll-Out
9.2.2.2 ALK Collaborates With EddingPharm to Boost China Sales
9.2.2.3 ALK-Abelló: Sales Forecast 2016-2026
9.2.2.4 ALK-Abelló: Allergic Rhinitis Drug Development Pipeline, 2016
9.3 GlaxoSmithKline (GSK)
9.3.1 GlaxoSmithKline: Allergic Rhinitis Drugs Portfolio, 2016
9.3.2 GlaxoSmithKline: Sales Forecast 2016-2026
9.4 Johnson & Johnson
9.4.1 Johnson & Johnson: Allergic Rhinitis Drugs Portfolio, 2016
9.4.2 Johnson & Johnson: Recent Developments
9.4.2.1 Manufacturing Recalls At McNeil Consumer Healthcare
9.4.2.2 Johnson & Johnson: Sales Forecast 2016-2026
9.5 Kyowa Hakko Kirin
9.5.1 Kyowa Hakko Kirin: Allergic Rhinitis Drugs Portfolio, 2015
9.5.2 Kyowa Hakko Kirin: Sales Forecast 2016-2026
9.6 Merck & Co.
9.6.1 Merck: Allergic Rhinitis Drugs Portfolio, 2016
9.6.2 Merck: Recent Developments
9.6.2.1 Bayer Acquires Merck’s Consumer Health Business
9.6.2.2 FDA Rejects Singulair OTC Switch
9.2.6.3 Merck: Sales Forecast 2016-2026
9.2.6.4 Merck: Allergic Rhinitis Drug Development Pipeline, 2016
9.7 Sanofi
9.7.1 Sanofi: Allergic Rhinitis Drugs Portfolio, 2016
9.7.2 Sanofi: Sales Forecast 2016-2026
9.8 Stallergenes Greer
9.8.1 Stallergenes: Allergic Rhinitis Drugs portfolio, 2015
9.8.2 Stallergenes Greer: Sales Forecast 2016-2026
9.8.3 Stallergenes Greer: Allergic Rhinitis Drug Development Pipeline, 2015
9.9 UCB
9.9.1 UCB: Allergic Rhinitis Drugs Portfolio, 2015
9.9.2 UCB: Sales Forecast 2016-2026
9.10 Other Leading Companies within the Allergic Rhinitis Drugs Market
10. Allergic Rhinitis Drugs: Research and Development Pipeline, 2016-2026
10.1 Trends and Developments in the Allergic Rhinitis Pipeline
10.2 The R&D Pipeline for Oral Antihistamines, 2016
10.2.1 Talion (bepotastine) – Mitsubishi Tanabe
10.2.2 ZPL-3893787 (histamine H4R antagonist) – Ziarco Pharma
10.3 The R&D Pipeline for Intranasal Corticosteroids, 2016
10.3.1 APC-3000 (HFA inhaled corticosteroid) – Adamis Pharmaceuticals
10.3.2 TBS-6 – Trimel Pharmaceuticals
10.4 The R&D Pipeline for Immunotherapy in Allergic Rhinitis, 2016
10.4.1 Actair (house dust mite SLIT; STG320) – Stallergenes/Shionogi & Co
10.4.2 AllerT (subcutaneous birch pollen immunotherapy) – Anergis
10.4.3 Depigoid Birch 5000 (birch pollen allergen extract, Leti Pharma
10.4.4 House Dust Mite SLIT-Tablet (MK-8237) – ALK-Abelló/Merck/Torii
10.4.5 Pollinex Quattro (subcutaneous immunotherapies) – Allergy Therapeutics
10.4.6 gp-ASIT+ (grass pollen allergen fragments) – Biotech Tools
10.4.7 Betula verrucosa (Bet v) 1 allergen – Stallergenes Greer
10.5 The R&D Pipeline for Other Allergic Rhinitis Drugs
10.5.1 S-555739 (prostaglandin D2 receptor antagonist) – Shionogi
10.5.2 DSP-3025/AZD-8848 (toll-like receptor 7 agonist) – Dainippon Sumitomo/ AstraZeneca
10.5.3 GSK2245035 (toll-like receptor 7 agonist) – GSK
10.5.4 HP-3060 (transdermal long-acting tape) – Hisamitsu
10.5.5 MRX-4 (anti-inflammatory agent) – Celsus Therapeutics
11. Qualitative Analysis of the Allergic Rhinitis Drugs Market, 2016-2026
11.1 Market Factors Influencing Allergic Rhinitis Drugs
11.2 SWOT Analysis Of The Global Allergic Rhinitis Drugs Market, 2016-2026
11.2.1 Strengths
11.2.1.1 OTC-Switch Facilitating Ease Of Consumer Access
11.2.1.2 The Established Role Of Allergic Rhinitis Drugs In Treatment
11.2.1.3 Allergic Rhinitis And The Rising Unmet Clinical Need
11.2.1.4 Rising Profile of Allergic Rhinitis In Various Regions Driving Healthcare Provision
11.2.2 Weaknesses
11.2.2.1 Intranasal Corticosteroids And Patients’ Satisfaction Rates
11.2.2.2 Increasing Penetration Of Generic Drug Products
11.2.2.3 The Challenge Raised By The Low Volume Of Pipeline Developments
11.2.3 Opportunities
11.2.3.1 Growth In Emerging Markets Outstripping Established Markets
11.2.3.2 Rx-to-OTC Switching And The Effects On Revenue Potential
11.2.3.3 Combination Drug Products Providing Rising Efficacy Profiles
11.2.3.4 The Emergence Of Immunotherapy In Allergic Rhinitis
11.2.4 Threats
11.2.4.1 Cost-Containment As A Growth Restraint
11.2.4.2 Rising Cost Of APIs And Manufacturing
11.2.4.3 Patent Expiries And The Resultant Loss Of Revenue
11.3 Porter’s Five Force Analysis of the Global Allergic Rhinitis Drugs Market, 2016-2026
11.3.1 Power of Buyers
11.3.2 Power Of Suppliers
11.3.3 Threat of Substitutes
11.3.4 Threat Of New Entrants
11.3.5 Rivalry Among Competitors
12. Conclusions
12.1 Overview of Current Market Conditions and Market Forecast, 2015-2026
12.2 Leading Sectors in the Allergic Rhinitis Drugs Market in 2015
12.3 Leading Regions in the Allergic Rhinitis Drugs Market in 2015
12.4 Leading Companies in the Allergic Rhinitis Drugs Market, 2015
12.5 What Does The Future Hold For Allergic Rhinitis Drugs?
【レポート販売概要】
■ タイトル：アレルギー性鼻炎治療薬の世界市場予測2016-2026■ 英文：Allergic Rhinitis Drugs Market Forecast 2016-2026
■ 発行日：2016年9月
■ 調査会社：visiongain
■ 商品コード：VGAIN61118
■ 調査対象地域：グローバル
- 世界のプロピオン酸及びプロピオン酸誘導体市場About Propionic Acid and Its Derivatives Propionic acid is a colorless liquid with a pungent smell. It is produced industrially through the hydrocarboxylation of ethylene with a nickel carbonyl catalyst. It is clear and miscible with water and almost all normal organic solvents. Propionic acid and its derivatives are used for various applications in different industries, including Cosmetics, Texti …
- 中央式空調装置の世界市場：冷水式エアコンディショナー、直接膨張式エアコンディショナーAbout Central Air Conditioning System A central air conditioning system distributes air through ductwork to provide cooling, ventilation, heating, and control humidity in houses, large commercial buildings, and industrial plants. The ductwork has an air handler, air supply system, air return duct, and grilles and register that circulates cooled air from central air conditioning units to the closed …
- 世界のビックデータ市場（2014 – 2020）：事業機会、課題、戦略、産業と市場予測“Big Data” originally emerged as a term to describe datasets whose size is beyond the ability of traditional databases to capture, store, manage and analyze. However, the scope of the term has significantly expanded over the years. Big Data not only refers to the data itself but also a set of technologies that capture, store, manage and analyze large and variable collections of data to solve compl …
- マイコトキシン試験の世界市場予測（～2022）：種類別（アフラトキシン、オクラトキシンA、パチュリン、フザリウム毒素群）、技術別（高速液体クロマトグラフ(HPLC)ベース、液体クロマトグラフィー・タンデム質量分析法(LC-MS / MS)ベース、免疫測定法ベース）、テスト食品別（飼料・食品）、地域別“Mycotoxin testing market projected to grow at a CAGR of 6.0%”The mycotoxin testing market is projected to reach USD 1.56 billion by 2022, at a CAGR of 6.0% from 2016 to 2022. The market is driven by factors such as humid atmospheric conditions leading to increase in mycotoxins production in food & feed products, implementation of stringent food safety regulations, international trade mandates, gr …
- 重合ロジンの世界市場2015Polymerized Rosin (CAS 8050-09-7) Market Research Report 2015 aims at providing comprehensive data on Polymerized Rosin market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Polymerized Rosin description, covers its application areas, manufacturing methods, patterns. It captures Polymerized Rosin market trends, pays close attention to Polymerized Rosi …
- タイヤ製造機の世界市場2019-2023111 pages, November 2018 About this market Tire building machinery manufacturers are using automation solutions to develop products with features such as high production output, high speed of production, consistent reliability, and flawless end-product quality. These machines can perform all these functions with minimal manpower and maintenance. Advancements in technology have also allowed the dev …
- 慣性計測装置（IMU）の世界市場予測（～2022年）：船舶、ナビゲーション、軍事、宇宙、商用Increased demand for accurate and reliable navigation is one of the significant factors driving the inertial measurement unit market. The inertial measurement unit market is projected to grow from an estimated USD 16.46 billion in 2017 to USD 21.74 billion by 2022, at a CAGR of 5.72% during the forecast period. This growth can be attributed to factors, such as high volume of production of consumer …
- 脂肪酸エステルの世界市場分析：製品別（中鎖トリグリセリド、モノステアリン酸グリセリル、イソプロピルエステル）、用途別（パーソナルケア･化粧品、潤滑剤、食品加工、界面活性剤･洗剤、医薬品）、セグメント予測The global Fatty Acid Ester Market is expected to reach USD 2.44 billion by 2022, according to a new report by Grand View Research, Inc. Growing consumer awareness and regulatory policies regarding bio-based polymers and products are vital factors for industry development over the forecast period. Global industry is expected to be driven by increasing fatty acid esters demand in personal care, cos …
- 中国の石炭産業分析：Analyzing the Coal Industry in ChinaChina is the third biggest country of coal resources in the world and its annual coal output and consumption rank number one in the world. Coal industry is the basic industry in China and it plays an important role in the construction of the Chinese economy and the development of the society. The Chinese coal industry has kept good development trends in recent years. The coal market is in great in …
- 世界のBFSI（銀行・金融サービス・保険）セキュリティ市場：物理的セキュリティ、サイバーセキュリティOver the last few decades, the operating environment of BFSI industry has changed significantly in terms of technological advancements and work flow processes. There has been continuous technological revolution in the banks and financial institutions in the form of ATMs, core banking, e-banking, mobile banking, and consequently many services came into existence such as Real Time Gross Settlement ( …
- 組立ライン用ロボットの世界市場2016-2020Technavio research analyst predicts the global assembly line robots market to grow steadily at a CAGR of 7% during the forecast period. The need for flexibility in plant operations is one of the primary drivers of the market. As most industries now serve their customers 24/7, employees are required to work round the clock. The adoption of robots has reduced the employee workload drastically. Monot …
- 石油コークスの世界市場：燃料グレードコークス、煆焼コークスAbout Petcoke Petcoke or petroleum coke is a porous solid infusible and insoluble dark grey to black mass composed of highly condensed aromatic polycyclic hydrocarbons with a small percentage of other organic compounds. Petcoke is a refinery by-product. Once all the valuable fractions have been extracted from crude oil, the residues or heavy fractions are subjected to additional processing known a …
- トロポニンの市場別医療検査数および販売予測This new report from Venture Planning Group provides analysis of Troponin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories PO …
- 世界のアクチュエーター市場動向及び予測(2014-2019)The global actuators market is estimated to be $37.38 billion in 2014, and it is expected to grow at a CAGR of 8.00% to reach $54.93 billion by 2019. The actuators market overall has numerous competitors in each sector such as industry automobile, health care, aerospace & defense, marine, and mining. The primary market players are from the U.S. and Europe; the players from these regions have the t …
- 建設産業における塗膜防水の世界市場2017-2021About Liquid Applied Membrane for the Construction Industry Waterproofing is crucial in any construction as water can damage the concrete and corrode the internal iron scaffolds, thereby posing a threat to the construction's integrity and safety. Waterproofing systems are a mixture of materials used to prevent the seepage of water into the structural elements of a building or its closed spaces, su …
